About this trial
This is a 16-week controlled treatment trial of an over-the -counter supplement, hydrogen water, for individuals with ME/CFS patients. An active treatment condition will be compared to a placebo-control condition. The study will also seek confirmation of heart rate variability (HRV) as a biomarker, that is, as a predictor of improvement vs. non-improvement to be assessed at treatment termination. The HRV biomarker hypothesis is based on a finding that High Frequency HRV (cardio-parasympathetic measure) biologically separated improvers and non-improvers in my previous ME/CFS observational study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18-65 of both sexes
considered physically capable and willing to perform the study tasks
Meet validated phone-screen eligibility for ME/CFS criteria
Participant has internet and computer
Disqualifiers
Cases of fatigue clearly attributable to self-report medical conditions such as untreated hypothyroidism, unstable diabetes mellitus, organ failure, chronic infections, and chronic inflammatory diseases, or AIDS. Kidney disease/renal failure is also an exclusion
Exclusionary psychiatric disorders include any psychosis, or alcohol/ substance abuse within two years prior to illness onset and any time afterward, and current or past depression with melancholic or psychotic features within 5 years prior to onset of ME/CFS or anytime afterward
Pregnancy is an exclusion.
Patients with BMI>35
Trial design
Parallel
Treatments tested in this trial
Placebo condition
Dietary supplement16 week intervention of magnesium pill without active ingredient of molecular hydrogen.
Molecular hydrogen produced by a metallic magnesium tablet, consumed 3x a day dissolved in water. Treatment duration is 16 weeks.
Dietary supplementThe 3 daily doses of molecular hydrogen scheduled for a 16 week intervention. This distinguishes it from the placebo comparator condition.
Treatment groups
Trial outcomes
Primary outcomes
Fatigue Severity Scale
Self-report measure of the effect of fatigue on functioning.
Secondary outcomes
SF-36 Physical Function Subscale
Self-report measure of how much health limits your ability to perform various types of physical activities.
Depression, Anxiety and Stress Scale
Self-report measures three related negative emotional states of depression, anxiety, and tension/stress.
Hassles and Uplifts Scale
Self-report measure of chronic minor stressors and positive everyday experiences.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fred Friedberg
Lead sponsor
Stony Brook University
Sponsor institution